NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

Biotechnology

Health Care

Therapeutics

NorthSea Therapeutics

Rob de Ree

Mats Blom

Stephen Harrison

David A. Fraser

Hilde H. Steineger

Detlef Schuppan

Scott Friedman

Arun Sanyal

Jonathan A. Leff

Søren Møller

John Kastelein

Sander Slootweg

Jordi Xiol

Morris J. Birnbaum

Dirk Kerstens

Richard Gaster

The Board Members at NorthSea Therapeutics provide strategic oversight and guidance, ensuring the company's clinical and scientific endeavors align with its mission to develop innovative lipid therapeutics. This group of experienced advisors and supervisors steers corporate governance, shapes research directions, and secures financial and operational sustainability.

Board Members

The Leadership Team at NorthSea Therapeutics is responsible for driving the strategic direction and operational success of the company. Comprising key executives such as the CEO, COO, CFO, CMO, and CSO, this team collaborates to ensure effective decision-making, oversee clinical development, manage financial health, and foster partnerships that advance the company’s innovative lipid therapeutics pipeline.

Leadership Team

NorthSea Therapeutics

Org chart

Board & advisors

Teams

Board Members

Leadership Team

Offices

NorthSea Therapeutics

Org chart

Board & advisors

Teams

Board Members

Leadership Team

Offices

Related companies